- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05382975
A Comprehensive Trauma-sensitive Approach to Physical Activity Promotion in Schools (CSPAP-T) (CSPAP-T)
Study Overview
Detailed Description
The Comprehensive School Physical Activity Program (CSPAP) is a multi-component approach by which schools use all opportunities for students to be physically active in 5 domains: physical education; physical activity during school; physical activity before and after school; staff involvement; and family and community engagement. Overall, CSPAP-based interventions have had small effect sizes in impacting youth PA, with larger effect sizes seen when more CSPAP domains are included. CSPAP-based interventions are the least effective, and have the most barriers to implementation and sustainability, in school districts that serve a student population that experience intersecting forms of disadvantage and discrimination. Core reasons for this include: (1) youth who have experienced trauma may have unique needs in PA settings, (2) Teachers/staff are not trained to meet the needs of youth who have experienced trauma in PA settings, and (3) staffing constrains the ability of schools to implement new opportunities for PA.
The effectiveness and implementation of a flexible, systems-level intervention to increase opportunities for trauma-sensitive PA in middle schools will be studied. The intervention seeks to support middle schools in increasing opportunities for trauma-sensitive PA practices in all CSPAP domains-addressing two core systems-level barriers to such implementation (staffing and teacher/staff training) and building in flexibility for setting-specific needs assessment and action planning. Core components include (1) provision of a dedicated staff member (via Americorps) to support school PA (via direct staffing and capacity building), (2) setting-specific needs assessment and action planning, and (3) professional development opportunities for teachers, staff, and coaches related to the provision of trauma-sensitive PA.
The study will use a stepped wedge design with a total of 8 middle schools, in which each school will be randomized to start the intervention at different time points. All schools will provide baseline data and will later switch to the intervention phase in random order and in 3 waves. Based on feasibility considerations, 2 schools will switch from control phase to intervention phase in wedge 1, 3 schools will be in wedge 2, and 3 schools will be in wedge 3. Each 2-year intervention phase will be followed by a year when data will be collected to assess sustainability of the intervention. In total, there will be 20 control phase data collections, 24 intervention phase data collections, and 16 data collections during maintenance phase, for a total of 1800 student-assessments (across all schools and all time periods for 20 control and 40 intervention or post-intervention periods). This study will:
- Assess how intervention exposure is associated with student (accelerometer-measured) PA
- Assess how intervention exposure is associated with student internalizing and externalizing symptoms and resilient psychosocial function functioning
- Assess how intervention exposure is associated with change in PA opportunities at the school level
- Explore systems-level barriers and facilitators to successful intervention implementation and maintenance.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Pooja Tandon, MD
- Phone Number: 206-884-1130
- Email: pooja.tandon@seattlechildrens.org
Study Contact Backup
- Name: Kim Garrett, MPH
- Phone Number: 206-884-5074
- Email: kim.garrett@seattlechildrens.org
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98101
- Recruiting
- Seattle Children's Research Institute
-
Contact:
- Pooja S Tandon, MD
- Email: pooja.tandon@seattlechildrens.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Adolescent Inclusion Criteria:
- Age 11-14 (inclusive)
- Attend one of the participating schools during the study period
Teacher/Staff Inclusion Criteria:
- Age 18 or older
- Work at one of the participating schools during the study period
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Wedge 1 includes Schools 1 and 2.
|
Trauma-adapted CSPAP delivery:
|
Other: Wedge 2 includes Schools 3, 4, and 5.
|
Trauma-adapted CSPAP delivery:
|
Other: Wedge 3 includes Schools 6, 7, and 8.
|
Trauma-adapted CSPAP delivery:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Physical Activity - Accelerometer measured.
Time Frame: 2 times per year (Fall, Spring) up to 3 years
|
This is the primary outcome for this study and will be collected from a gender stratified random subset of at least 45 students per school, at each time point.
Physical activity will be objectively measured using the ActiGraph GT3X worn at the hip for 7 day periods (x 24 hour wear) at each of the data collection timepoints (i.e., fall and spring of each school year).
|
2 times per year (Fall, Spring) up to 3 years
|
Change in Internalizing and Externalizing Symptoms.
Time Frame: 2 times per year (Fall, Spring) up to 3 years
|
Mental health symptomatology will be measured using the Strengths and Difficulties Questionnaire (self-report version for 11-16 year olds), a brief behavioral screening questionnaire.
Scores will be calculated for internalizing problems (emotional+peer symptoms, 10 items, scale 0-20) and externalizing problems (conduct+hyperactivity symptoms, 10 items, scale 0-20).
This will be asked in surveys digitally distributed to all students in the fall and spring of each school year.
Higher scores indicate worse outcomes.
|
2 times per year (Fall, Spring) up to 3 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Resilient psychosocial functioning
Time Frame: 2 times per year (Fall, Spring) up to 3 years
|
Psychological aspects of adolescent resilience will be measured using the 21-item Adolescent Resilience Scale.
This three-factor scale measures emotional regulation, positive future orientation, and novelty seeking.
This will be asked in surveys digitally distributed to all students in the fall and spring of each school year.
|
2 times per year (Fall, Spring) up to 3 years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
School-level physical activity
Time Frame: 2 times per year (Fall, Spring) up to 3 years
|
The SOPLAY (System of Observing Play and Leisure Activity in Youth) is a validated observation tool designed to obtain observational data on the number of students, their physical activity levels in a specified area (target area) where physical activity could occur, and the predominant type of activity.
Data collection will occur for 3 days at each time point, at each school during data collection periods (i.e., fall and spring of each school year) to assess proportion of children engaging in moderate to vigorous physical activity in the various target areas.
|
2 times per year (Fall, Spring) up to 3 years
|
School-level physical activity practices.
Time Frame: 2 times per year (Fall, Spring) up to 3 years
|
School administrators will complete the Comprehensive School Physical Activity Program Questionnaire (CSPAP-Q) to measure school-level physical activity practices.
|
2 times per year (Fall, Spring) up to 3 years
|
School level trauma-sensitive practices
Time Frame: 2 times per year (Fall, Spring) up to 3 years
|
School administrators will complete the Trauma Responsive School Implementation Assessment to assess the implementation of trauma-sensitive practices at the school
|
2 times per year (Fall, Spring) up to 3 years
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00003419
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Physical Activity
-
Istinye UniversityCompletedPhysical Activity | Youth | Physical Activity Barriers | Physical Activity FacilitatorsTurkey
-
Istanbul Kültür UniversityWithdrawnPhysical Activity Level | Physical Activity Awareness
-
Georgetown UniversityUniversity of PennsylvaniaCompletedPhysical Activity | Motor ActivityUnited States
-
University of Texas, El PasoNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingPhysical Activity | Activity TrackersUnited States
-
Assistance Publique - Hôpitaux de ParisTerminatedPhysical Activity | Physical DisabilityFrance
-
University of Colorado, DenverCompletedPhysical Activity | Physical ImpairmentUnited States
-
PXL University CollegeHasselt UniversityNot yet recruitingPhysical Activity - Digital Phenotyping - Activity Tracking
-
University of ExtremaduraThe Spanish Ministry of Science, Innovation and UniversitiesRecruitingPhysical Activity | Cognition | Physical Fitness | AdolescentsSpain
-
AdventHealth Translational Research InstituteWake Forest UniversityRecruiting
-
Wake Forest University Health SciencesMayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases... and other collaboratorsRecruitingPhysical ActivityUnited States
Clinical Trials on CSPAP-T
-
Wake Forest University Health SciencesNational Heart, Lung, and Blood Institute (NHLBI); University of South CarolinaCompleted
-
Biotronik SE & Co. KGCompletedHeart Failure | BradycardiaDenmark, Hong Kong, Austria, Germany, Belgium
-
University of California, BerkeleyUniversity of Nevada, Reno; World Bank; L'Office National de Nutrition, MadagascarRecruitingEarly Childhood DevelopmentMadagascar
-
Biotronik SE & Co. KGCompletedVentricular Fibrillation | Ventricular TachycardiaGermany, Czech Republic
-
University of South FloridaNational Cancer Institute (NCI)RecruitingCancer | Obesity, Childhood | SurvivorshipUnited States
-
Hebei Senlang Biotechnology Inc., Ltd.RecruitingLymphoma | Multiple Myeloma | Acute Lymphoblastic LeukemiaChina
-
Xuzhou Medical UniversityNot yet recruiting
-
The First Affiliated Hospital of Soochow UniversityRecruitingRelapsed/Refractory B-cell Non-Hodgkin's LymphomaChina
-
City of Hope Medical CenterNational Cancer Institute (NCI); California Institute for Regenerative Medicine...RecruitingBreast Cancer | HER2-positive Breast Cancer | Malignant Neoplasm | Metastatic Malignant Neoplasm in the Brain | Metastatic Malignant Neoplasm in the LeptomeningesUnited States
-
Everett MeyerNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedLymphoma, Non-Hodgkin | Acute Myeloid Leukemia | Acute Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Myelodysplastic Syndromes (MDS) | Acute Lymphoblastic Leukemia (ALL) | Myeloid Leukemia, Chronic | Myeloproliferative SyndromeUnited States